Announcements Trials

Browse Landscape

Phase

Phase 2 3 Phase 4 1 Phase 3 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma 1 Neoplasm Metastasis 1

Interventions

pembrolizumab 130 Carboplatin 127 Cisplatin 118 Paclitaxel 99 Gemcitabine 87 Specimen Handling 80 Magnetic Resonance Spectroscopy 80 Docetaxel 70 Dexamethasone 62 Cyclophosphamide 61 Pemetrexed 59 Capecitabine 56 Bevacizumab 56 durvalumab 52 Oxaliplatin 52 Fluorouracil 50 Doxorubicin 49 Radiotherapy 48 Leucovorin 45 Radiation 44 Rituximab 43 Lenalidomide 42 Vincristine 39 Etoposide 36 Nivolumab 34 atezolizumab 33 Letrozole 32 130-nm albumin-bound paclitaxel 32 Irinotecan 31 Prednisone 29

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × capmatinib × 90 days × Clear all

NCT03784014 2026-04-29

MULTISARC

Institut National de la Santé Et de la Recherche Médicale, France

Phase 3 Completed

Neoplasm Metastasis, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡